Activation of EHF via STAT3 phosphorylation by LMP2A in Epstein‐Barr virus–positive gastric cancer
Open Access
- 20 May 2021
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 112 (8) , 3349-3362
Abstract
Epstein‐Barr virus (EBV) is associated with approximately 10% of gastric cancers (GCs). We previously showed that EBV infection of gastric epithelial cells induces aberrant DNA methylation in promoter regions, which causes silencing of critical tumor suppressor genes. Here, we analyzed gene expressions and active histone modifications (H3K4me3, H3K4me1, and H3K27ac) genome‐widely in EBV‐positive GC cell lines and in vitro EBV‐infected GC cell lines to elucidate the transcription factors contributing to tumorigenesis through enhancer activation. Genes associated with “signaling of WNT in cancer” were significantly enriched in EBV‐positive GC, showing increased active β‐catenin staining. Genes neighboring activated enhancers were significantly upregulated, and EHF motif was significantly enriched in these active enhancers. Higher expression of EHF in clinical EBV‐positive GC compared with normal tissue and EBV‐negative GC was confirmed by RNA‐seq using The Cancer Genome Atlas cohort, and by immunostaining using our cohort. EHF knockdown markedly inhibited cell proliferation. Moreover, there was significant enrichment of critical cancer pathway–related genes (eg, FZD5) in the downstream of EHF. EBV protein LMP2A caused upregulation of EHF via phosphorylation of STAT3. STAT3 knockdown was shown to inhibit cellular growth of EBV‐positive GC cells, and the inhibition was rescued by EHF overexpression. Our data highlighted the important role of EBV infection in gastric tumorigenesis via enhancer activation.Keywords
Funding Information
- Japan Society for the Promotion of Science (19H03726, 19K16101)
- Japan Agency for Medical Research and Development (P‐CREATE 19cm0106510h0004)
- Chiba University (2018‐Y9, 2018‐S6, 2019‐S6)
This publication has 36 references indexed in Scilit:
- Comprehensive molecular characterization of gastric adenocarcinomaNature, 2014
- Enhancer Malfunction in CancerMolecular Cell, 2014
- Classification of Epstein–Barr Virus–Positive Gastric Cancers by Definition of DNA Methylation EpigenotypesCancer Research, 2011
- Meta-analysis Shows That Prevalence of Epstein–Barr Virus-Positive Gastric Cancer Differs Based on Sex and Anatomic LocationGastroenterology, 2009
- Activation of DNA Methyltransferase 1 by EBV Latent Membrane Protein 2A Leads to Promoter Hypermethylation of PTEN Gene in Gastric CarcinomaCancer Research, 2009
- Epstein–Barr virus and gastric carcinoma: virus–host interactions leading to carcinomaCancer Science, 2008
- The Epigenomics of CancerCell, 2007
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001
- Ets target genes: past, present and futureOncogene, 2000
- DNA sequence and expression of the B95-8 Epstein—Barr virus genomeNature, 1984